These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 26638769)

  • 1. Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function.
    Sagheddu C; Muntoni AL; Pistis M; Melis M
    Int Rev Neurobiol; 2015; 125():257-302. PubMed ID: 26638769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocannabinoid system and nondrug rewarding behaviours.
    Fattore L; Melis M; Fadda P; Pistis M; Fratta W
    Exp Neurol; 2010 Jul; 224(1):23-36. PubMed ID: 20353776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid signalling in reward and addiction.
    Parsons LH; Hurd YL
    Nat Rev Neurosci; 2015 Oct; 16(10):579-94. PubMed ID: 26373473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.
    Zlebnik NE; Cheer JF
    J Neurosci; 2016 Oct; 36(40):10230-10238. PubMed ID: 27707960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurobiology of pleasure, reward processes, addiction and their health implications.
    Esch T; Stefano GB
    Neuro Endocrinol Lett; 2004 Aug; 25(4):235-51. PubMed ID: 15361811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid signaling system and brain reward: emphasis on dopamine.
    Gardner EL
    Pharmacol Biochem Behav; 2005 Jun; 81(2):263-84. PubMed ID: 15936806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and Addiction.
    Peters KZ; Oleson EB; Cheer JF
    Cold Spring Harb Perspect Med; 2021 Jan; 11(1):. PubMed ID: 31964646
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of basal ganglia and orbitofrontal cortex in goal-directed behavior.
    Hollerman JR; Tremblay L; Schultz W
    Prog Brain Res; 2000; 126():193-215. PubMed ID: 11105648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
.
    Spanagel R
    Dialogues Clin Neurosci; 2020 Sep; 22(3):241-250. PubMed ID: 33162767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Augmentation of Endocannabinoid Levels Persistently Increases Dopaminergic Encoding of Reward Cost and Motivation.
    Covey DP; Hernandez E; Luján MÁ; Cheer JF
    J Neurosci; 2021 Aug; 41(32):6946-6953. PubMed ID: 34230105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine, motivation, and the evolutionary significance of gambling-like behaviour.
    Anselme P
    Behav Brain Res; 2013 Nov; 256():1-4. PubMed ID: 23896052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of brain reward by the endocannabinoid system: a critical review of behavioral studies in animals.
    Vlachou S; Panagis G
    Curr Pharm Des; 2014; 20(13):2072-88. PubMed ID: 23829366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liking, wanting, and the incentive-sensitization theory of addiction.
    Berridge KC; Robinson TE
    Am Psychol; 2016 Nov; 71(8):670-679. PubMed ID: 27977239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitionality in addiction: A "temporal continuum" hypotheses involving the aberrant motivation, the hedonic dysregulation, and the aberrant learning.
    Patrono E; Gasbarri A; Tomaz C; Nishijo H
    Med Hypotheses; 2016 Aug; 93():62-70. PubMed ID: 27372858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system.
    Sagheddu C; Melis M
    CNS Neurol Disord Drug Targets; 2015; 14(4):502-17. PubMed ID: 25714966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An endocannabinoid hypothesis of drug reward and drug addiction.
    Onaivi ES
    Ann N Y Acad Sci; 2008 Oct; 1139():412-21. PubMed ID: 18991888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance.
    Everett TJ; Gomez DM; Hamilton LR; Oleson EB
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110031. PubMed ID: 32663486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FNDC5/irisin, a molecular target for boosting reward-related learning and motivation.
    Zsuga J; Tajti G; Papp C; Juhasz B; Gesztelyi R
    Med Hypotheses; 2016 May; 90():23-8. PubMed ID: 27063080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid signaling and food addiction.
    D'Addario C; Micioni Di Bonaventura MV; Pucci M; Romano A; Gaetani S; Ciccocioppo R; Cifani C; Maccarrone M
    Neurosci Biobehav Rev; 2014 Nov; 47():203-24. PubMed ID: 25173635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence.
    Brabant C; Alleva L; Quertemont E; Tirelli E
    Prog Neurobiol; 2010 Nov; 92(3):421-41. PubMed ID: 20638439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.